Published February 15, 2019 | Version v1
Journal article

Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future

  • 1. Sapporo Medical University, Department of Surgery, Surgical Oncology and Science (Japan)
  • 2. Tohoku University Graduate School of Medicine, Department of Surgery (Japan)
  • 3. Hamamatsu University School of Medicine, Second Department of Surgery (Japan)
  • 4. Osaka General Medical Center (Japan)
  • 5. Hamamatsu University School of Medicine (Japan)
  • 6. National Cancer Center, Center for Cancer Control and Information Services (Japan)
  • 7. Tokyo Medical and Dental University (Japan)
  • 8. Keio University, Department of Health Policy and Management, School of Medicine (Japan)
  • 9. Gunma University Graduate School of Medicine, Department of Molecular Pharmacology and Oncology (Japan)
  • 10. Hirosaki University Graduate School of Medicine, Department of Gastroenterological Surgery (Japan)
  • 11. St. Luke's International University (Japan)
  • 12. Keio University Law School (Japan)
  • 13. Osaka University, Department of Gastroenterological Surgery, Graduate School of Medicine (Japan)
  • 14. The University of Tokyo, Healthcare Quality Assessment (Japan)
  • 15. Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterological Surgery (Japan)

Description

Background

The current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines.

Methods

A questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare.

Results

Most organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary.

Conclusion

In Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.

Additional details

Identifiers

Publishing Information

Journal Title
International Journal of Clinical Oncology
Journal Volume
24
Journal Issue
2
Journal Page Range
p. 189-195
ISSN
1341-9625

INIS

Country of Publication
Japan
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54122189
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BUDGETS; LEGAL ASPECTS; NATIONAL GOVERNMENT; NEOPLASMS; PERSONNEL; RECOMMENDATIONS; STATE GOVERNMENT; VALIDATION
Descriptors DEC
DISEASES; TESTING

Optional Information

Copyright
Copyright (c) 2018 The Author(s)